Skip to content

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Abductor Insufficiency After Total Hip Arthroplasty; Risk Factors and Diagnosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05216666
Acronym
HSS
Enrollment
580
Registered
2022-01-31
Start date
2022-05-11
Completion date
2028-12-31
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Muscle Weakness, Muscle Atrophy, Muscle Injury, Arthroplasty Complications

Keywords

abductor, approach, limp, Trendelenburg, gluteus medius

Brief summary

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.

Detailed description

The use of lateral approach has been empirically associated with increased risk of abductor insufficiency and limping after total hip arthroplasty compared with the posterior approach. However lateral approach remains a widespread technik because it provides a decreased risk of dislocation. In litterature, gluteus medius insufficiency has been reported even when the posterior approach has been used. In the early stage of postperative relhabilitation it is difficult to distinguish between between limping that resolves after abductor training and limping due to abductor injury/avulsion that is resistent to physiotherapy. The purpose of this randomized controlled trial is to compare the risk of persistent limping one year after total hip arthtoplasty between lateral and posterior approach and to identify patient-related risk factors for limping. Moreover it will validate ultra sound (U/S), magnetic resonance imaging (MRI) of the hip and gait analysis as diagnostic tools for early detection of limping that is going to persist one year after total hip arthroplasty. 580 patients will hip osteoarthritis be randomised to receive their total hip arthroplasty through an either lateral of posterior approach and will be followed at one year with physical examination (Trendelenburg sign) and patient.-reported outcome measures. Patients with a positive Trendelenburg sign at 3 months will undergo U/S and MRI examination as well as gait analysis and reassessed at one year with physical examination. The first 40 patients with negative Trendelenburg sign at 3 months will also undergo U/S, MRI and gait analysis. The specificity and sensitivity of U/S, MRI and gait analysis for positiv Trendelenburg sign will be calculated.

Interventions

Total hip arthroplasty performed through a lateral surgical approach (Gammer)

Total hip arthroplasty performed through a posterior surgical approach (Moore)

Sponsors

Vastra Gotaland Region
CollaboratorOTHER_GOV
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty. * Ability to understand and write swedish.

Exclusion criteria

* Impaired funktion of the contralateral hip or knees causing limping. * Neuromuscular diseases * Postoperative leg length discrepancy excceding 1 cm * Postoperative discrepancy in femoral offset exceeding 25% of the femoral offset of the contralateral hip.

Design outcomes

Primary

MeasureTime frameDescription
Trendelenburg sign as binary variable (positive/negative)At 12 months after interventionTrendelenburg sign negative if the pelvis remains horisontal while standing only on the operated leg with both arms in anatomical postion. If the pelvismcannot be kept horisontal and tilts towards the kontralateral hip the Trendelenburgs sign is regarded as positive.

Secondary

MeasureTime frameDescription
Intraoperative blood lossIntraoperativeBleeding during total hip arthroplasty measured in ml
Periprosthetic infectionWithin 12 months from interventionIncidens of deep surgical wound infection
Oxford Hip ScoreAt 3 months after interventionPatient-reported hip function measured in a scale of 0-48
Euroqol 5 dimension 5 level index (EQ5D-5L)At 3 months after interventionPatient-reported health-related quality of life measured with the swedish version of euroqol 5 dimension 5 level index 0-1
Euroqol visual analog scale (EQVAS)At 3 months after interventionPatient-reported health-related quality of life measured with the euroqol visual analog scale 0-100
DislocationWithin 12 months from interventionIncidens of postoperative dislocation
Gluteus medius avulsion in ultrasoundAt 3 months after interventionThe proportion avulsed gluteus medius tendon in relation to the whole tendon attachment in a scale of 0 (no avulsion) to 1 (total avulsion). Measured with ultrasound
Gluteus medius atrophy in Magnetic Resonance ImagingAt 3 months after interventionThe area of gluteus medius muscle in the operated side divided by the area of the gluteus medius muscle in the healthy side as shown in magnetic resonance imaging in a scale of 0 (complete atrophy) to 1 (no atrophy)
Hip abuction torqueAt 3 months after interventionHip abuction torque measured in Nm/Kg with gate analysis
Trendelenburg sign as binary variable (positive/negative)At 3 months after interventionTrendelenburg sign negative if the pelvis remains horisontal while standing only on the operated leg with both arms in anatomical postion. If the pelvismcannot be kept horisontal and tilts towards the kontralateral hip the Trendelenburgs sign is regarded as positive.
University of California Activity Level (UCLA)At 3 months after interventionPatient-reported acivity level measured with the University of California Level of Acivity rank scale 0-10

Countries

Sweden

Contacts

Primary ContactGeorgios Tsikandylakis, MD PhD
tsikandylakis@gmail.com0046313421000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026